Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy.

Zhou JG, Yang J, Wang H, Wong AH, Tan F, Chen X, He SS, Shen G, Wang YJ, Frey B, Fietkau R, Hecht M, Zhong W, Ma H, Gaipl U

Open source

DOI: 10.1136/bmjonc-2023-000128
Published: 2024
Container: BMJ oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjonc-2023-000128,
  title = {Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy.},
  author = {Zhou JG and Yang J and Wang H and Wong AH and Tan F and Chen X and He SS and Shen G and Wang YJ and Frey B and Fietkau R and Hecht M and Zhong W and Ma H and Gaipl U},
  year = {2024},
  journal = {BMJ oncology},
  doi = {10.1136/bmjonc-2023-000128},
  url = {https://doi.org/10.1136/bmjonc-2023-000128}
}

RIS

TY  - JOUR
TI  - Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy.
AU  - Zhou JG
AU  - Yang J
AU  - Wang H
AU  - Wong AH
AU  - Tan F
AU  - Chen X
AU  - He SS
AU  - Shen G
AU  - Wang YJ
AU  - Frey B
AU  - Fietkau R
AU  - Hecht M
AU  - Zhong W
AU  - Ma H
AU  - Gaipl U
PY  - 2024
JO  - BMJ oncology
DO  - 10.1136/bmjonc-2023-000128
UR  - https://doi.org/10.1136/bmjonc-2023-000128
ER  -

APA

JG, Z., J, Y., H, W., AH, W., F, T., X, C., SS, H., G, S., YJ, W., B, F., R, F., M, H., W, Z., H, M., & U, G. (2024). Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy.. BMJ oncology. https://doi.org/10.1136/bmjonc-2023-000128

Source records

pubmed · retrieved 2026-09-26T02:24:27.280Z